Τίτλος:
Randomized phase III trial on niraparib - TSR-042 (dostarlimab) vs
physician's choice CHEmotherapy in recurrent ovarian, fallopian tube or
primary peritoneal cancer patients not candidate for platinum
retreatment: NItCHE trial (MITO 33)
Συγγραφείς:
Lorusso, D.
Musacchio, L.
Pignata, S.
Braicu, E. I. and
Cibula, D.
Colombo, N.
Frenel, J-S.
Zagouri, F.
Carbone,
V.
Ghizzoni, V.
Giolitto, S.
Giudice, E.
Landolfo, C.
and Perri, M. T.
Ricci, C.
Salutari, V.
Scambia, G.
